Chenxin Pharmaceuticals: Shareholder Chen Xin Tong Tai plans to reduce their stake by no more than 1%.

Chenxin Pharmaceutical announced that shareholder Jiangsu Chenxin Tongtai Enterprise Management Co., Ltd. holds 1.3683 million shares of the company, accounting for 0.302%. They plan to reduce their holding by no more than 1.3683 million shares through centralized bidding or block trading within 3 months after the disclosure date, with a reduction ratio not exceeding 1%; the reduction period is from April 7, 2026 to July 7, 2026, and the shares come from the distribution of shares split from Chenxin Technology Group, for funding needs.